BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15044251)

  • 1. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.
    Guiter C; Dusanter-Fourt I; Copie-Bergman C; Boulland ML; Le Gouvello S; Gaulard P; Leroy K; Castellano F
    Blood; 2004 Jul; 104(2):543-9. PubMed ID: 15044251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma.
    Miloudi H; Leroy K; Jardin F; Sola B
    Cell Signal; 2018 Jun; 46():76-82. PubMed ID: 29501729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.
    Ritz O; Guiter C; Castellano F; Dorsch K; Melzner J; Jais JP; Dubois G; Gaulard P; Möller P; Leroy K
    Blood; 2009 Aug; 114(6):1236-42. PubMed ID: 19423726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets.
    Raia V; Schilling M; Böhm M; Hahn B; Kowarsch A; Raue A; Sticht C; Bohl S; Saile M; Möller P; Gretz N; Timmer J; Theis F; Lehmann WD; Lichter P; Klingmüller U
    Cancer Res; 2011 Feb; 71(3):693-704. PubMed ID: 21127196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL).
    Ritz O; Rommel K; Dorsch K; Kelsch E; Melzner J; Buck M; Leroy K; Papadopoulou V; Wagner S; Marienfeld R; Brüderlein S; Lennerz JK; Möller P
    Oncotarget; 2013 Jul; 4(7):1093-102. PubMed ID: 23852366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.
    Lu X; Nechushtan H; Ding F; Rosado MF; Singal R; Alizadeh AA; Lossos IS
    Blood; 2005 Apr; 105(7):2924-32. PubMed ID: 15591113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line.
    Melzner I; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Barth TF; Leithäuser F; Möller P
    Blood; 2005 Mar; 105(6):2535-42. PubMed ID: 15572583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
    Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
    Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
    Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
    Savage KJ; Monti S; Kutok JL; Cattoretti G; Neuberg D; De Leval L; Kurtin P; Dal Cin P; Ladd C; Feuerhake F; Aguiar RC; Li S; Salles G; Berger F; Jing W; Pinkus GS; Habermann T; Dalla-Favera R; Harris NL; Aster JC; Golub TR; Shipp MA
    Blood; 2003 Dec; 102(12):3871-9. PubMed ID: 12933571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of DLBCL with a PMBL gene expression signature.
    Duns G; Viganò E; Ennishi D; Sarkozy C; Hung SS; Chavez E; Takata K; Rushton C; Jiang A; Ben-Neriah S; Woolcock BW; Slack GW; Hsi ED; Craig JW; Hilton LK; Shah SP; Farinha P; Mottok A; Gascoyne RD; Morin RD; Savage KJ; Scott DW; Steidl C
    Blood; 2021 Jul; 138(2):136-148. PubMed ID: 33684939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo.
    Hao Y; Chapuy B; Monti S; Sun HH; Rodig SJ; Shipp MA
    Clin Cancer Res; 2014 May; 20(10):2674-83. PubMed ID: 24610827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIM Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity.
    Szydłowski M; Dębek S; Prochorec-Sobieszek M; Szołkowska M; Tomirotti AM; Juszczyński P; Szumera-Ciećkiewicz A
    Am J Pathol; 2021 Mar; 191(3):567-574. PubMed ID: 33307035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling.
    Yuan J; Wright G; Rosenwald A; Steidl C; Gascoyne RD; Connors JM; Mottok A; Weisenburger DD; Greiner TC; Fu K; Smith L; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Ott G; Vose JM; Staudt LM; Chan WC;
    Am J Surg Pathol; 2015 Oct; 39(10):1322-30. PubMed ID: 26135560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling.
    Murata T; Noguchi PD; Puri RK
    J Immunol; 1996 Apr; 156(8):2972-8. PubMed ID: 8609418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction.
    Murata T; Obiri NI; Puri RK
    Int J Cancer; 1997 Jan; 70(2):230-40. PubMed ID: 9009165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
    Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
    Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.
    Mottok A; Hung SS; Chavez EA; Woolcock B; Telenius A; Chong LC; Meissner B; Nakamura H; Rushton C; Viganò E; Sarkozy C; Gascoyne RD; Connors JM; Ben-Neriah S; Mungall A; Marra MA; Siebert R; Scott DW; Savage KJ; Steidl C
    Blood; 2019 Sep; 134(10):802-813. PubMed ID: 31292115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hematopoietic cell lines: in vitro models for the study of primary mediastinal B-cell lymphomas.
    Drexler HG; Ehrentraut S; Nagel S; Eberth S; MacLeod RA
    Leuk Res; 2015 Jan; 39(1):18-29. PubMed ID: 25480038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells.
    Murata T; Puri RK
    Cell Immunol; 1997 Jan; 175(1):33-40. PubMed ID: 9015186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.